The global market for Inactivated Influenza Virus Vaccine is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor. The APAC Inactivated Influenza Virus Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028. The United States Inactivated Influenza Virus Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028. The Europe Inactivated Influenza Virus Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028. The China Inactivated Influenza Virus Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028. Global key Inactivated Influenza Virus Vaccine players cover CSL, GSK, Sanofi Pasteur, Mylan and AstraZeneca, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021. Report Coverage This latest report provides a deep insight into the global Inactivated Influenza Virus Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc. This report aims to provide a comprehensive picture of the global Inactivated Influenza Virus Vaccine market, with both quantitative and qualitative data, to help readers understand how the Inactivated Influenza Virus Vaccine market scenario changed across the globe during the pandemic and Russia-Ukraine War. The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units. Market Segmentation: The study segments the Inactivated Influenza Virus Vaccine market and forecasts the market size by Type (Whole Virus Vaccine and Subunit Vaccine,), by Application (Hospital and Clinic.), and region (APAC, Americas, Europe, and Middle East & Africa). Segmentation by type Whole Virus Vaccine Subunit Vaccine Segmentation by application Hospital Clinic Segmentation by region Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries Major companies covered CSL GSK Sanofi Pasteur Mylan AstraZeneca Pfizer Johnson & Johnson Jiangsu Jindik Biotechnology Co., Ltd Beijing Kexing Biological Products Co., Ltd Jiangsu Kangrun Biotechnology Co., Ltd Hualan Bio Vaccines Co., Ltd Dalian Yalifeng Biopharmaceutical Co., Ltd Shanghai Institute of Biological Products Co., Ltd Changchun Institute of Biological Products Co., Ltd Lanzhou Institute of Biological Products Co., Ltd Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Emmi Chengxin Biopharmaceutical Co., Ltd Chapter Introduction Chapter 1: Scope of Inactivated Influenza Virus Vaccine, Research Methodology, etc. Chapter 2: Executive Summary, global Inactivated Influenza Virus Vaccine market size (sales and revenue) and CAGR, Inactivated Influenza Virus Vaccine market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028. Chapter 3: Inactivated Influenza Virus Vaccine sales, revenue, average price, global market share, and industry ranking by company, 2017-2022 Chapter 4: Global Inactivated Influenza Virus Vaccine sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa. Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type. Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace Chapter 10: Manufacturing cost structure analysis Chapter 11: Sales channel, distributors, and customers Chapter 12: Global Inactivated Influenza Virus Vaccine market size forecast by region, by country, by type, and application. Chapter 13: Comprehensive company profiles of the leading players, including CSL, GSK, Sanofi Pasteur, Mylan, AstraZeneca, Pfizer, Johnson & Johnson, Jiangsu Jindik Biotechnology Co., Ltd and Beijing Kexing Biological Products Co., Ltd, etc. Chapter 14: Research Findings and Conclusion
1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Inactivated Influenza Virus Vaccine Annual Sales 2017-2028 2.1.2 World Current & Futu
